Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Australian Journal of Primary Health|October 22, 2013
'Catching chlamydia': combining cash incentives and community pharmacy access for increased chlamydia screening, the view of young peopleRhian M Parker, Allison Bell, Marian J Currie, et al.Australian Journal of General Practice|August 18, 2018
What can pharmacists do in general practice? A pilot trialLouise S Deeks, Mark Naunton, Guan Han Tay, et al.Nature Medicine|January 12, 1999
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humansM Hellerstein, M B Hanley, D Cesar, et al.Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|May 18, 2018
Canadian vaccine research networks: Vaccine safety resources for CanadaJ McCarthy, S A Halperin, J A Bettinger, et al.JAMA|December 28, 1999
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trialJ Kahn, S Lagakos, M Wulfsohn, et al.Genes and Immunity|September 23, 2011
The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cARTR Rajasuriar, D R Booth, M Gouillou, et al.Journal of Neurovirology|March 10, 2015
HIV eradication symposium: will the brain be left behind?B J Brew, K Robertson, E J Wright, et al.AIDS (London, England)|October 2, 2001
Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic functionL Teixeira, H Valdez, J M McCune, et al.British Journal of Haematology|June 3, 2022
Impaired humoral and cellular response to primary COVID-19 vaccination in patients less than 2 years after allogeneic bone marrow transplantSam M Murray, Maria Barbanti, Cori Campbell, et al.Mbio|September 1, 2023
CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH studyIsabel Neale, Mohammad Ali, Barbara Kronsteiner, et al.Pageof 5